FDA recall D-0391-2025
Preferred Pharmaceuticals, Inc. · Class II · drug
Product
Clindamycin Hydrochloride Capsules, USP, 300mg, 30-count bottles, Manufactured by: Glenmark Pharmaceuticals Limited, NDC 68788-8685-03.
Reason for recall
cGMP Deviations
Distribution
Nationwide in the US
Key facts
- Status
- Ongoing
- Initiation date
- 2025-04-18
- Report date
- 2025-05-07
- Voluntary/Mandated
- Voluntary: Firm initiated
- Location
- Anaheim, CA, United States
Primary source
https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0391-2025